AI assistant
Sending…
Pacira BioSciences, Inc. — Director's Dealing 2015
Aug 20, 2015
32125_dirs_2015-08-19_88f9e430-c056-4f53-a035-46e7bdd4940a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2015-08-17
Reporting Person: Jones James B (SVP & Chief Medical Officer)
More from Pacira BioSciences, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 19
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 12
Interim / Quarterly Report
2026
Apr 30